Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders
- 20 January 2004
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 18 (3) , 511-518
- https://doi.org/10.1096/fj.03-0739com
Abstract
Alzheimer’s disease (AD) and several other neurological disorders have been linked to the overactivation of glutamatergic transmission and excitotoxicity as a common pathway of neuronal injury. The β-amyloid peptide (Aβ) is centrally related to the pathogenesis of AD, and previous reports have demonstrated that the blockade of glutamate receptors prevents Aβ–induced neuronal death. We show that taurine, a β-amino acid found at high concentrations in the brain, protects chick retinal neurons in culture against the neurotoxicity of Aβ and glutamate receptor agonists. The protective effect of taurine is not mediated by interaction with glutamate receptors, as demonstrated by binding studies using radiolabeled glutamate receptor ligands. The neuroprotective action of taurine is blocked by picrotoxin, an antagonist of GABAA receptors. GABA and the GABAA receptor agonists phenobarbital and melatonin also protect neurons against Aβ-induced neurotoxicity. These results suggest that activation of GABA receptors decreases neuronal vulnerability to excitotoxic damage and that pharmacological manipulation of the excitatory and inhibitory neurotransmitter tonus may protect neurons against a variety of insults. GABAergic transmission may represent a promising target for the treatment of AD and other neurological disorders in which excitotoxicity plays a relevant role.—Louzada, P. R., Lima, A. C. P., Mendonça-Silva, D. L., Noël, F., de Mello, F. G., Ferreira, S. T. Taurine prevents the neurotoxicity of β-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer’s disease and other neurological disorders.Keywords
Funding Information
- John Simon Guggenheim Memorial Foundation
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
This publication has 53 references indexed in Scilit:
- Neuroprotective Effect of Somatostatin on Nonapoptotic NMDA-Induced Neuronal Death: Role of Cyclic GMPJournal of Neurochemistry, 2002
- Role of Group II and Group III Metabotropic Glutamate Receptors in Spinal Cord InjuryExperimental Neurology, 2002
- Inhibition of choline acetyltransferase by excitatory amino acids as a possible mechanism for cholinergic dysfunction in the central nervous systemJournal of Neurochemistry, 2001
- High extracellular γ‐aminobutyric acid protects cultured neurons against damage induced by the accumulation of endogenous extracellular glutamateJournal of Neuroscience Research, 2001
- Inhibition of Alzheimer's disease β‐amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapyThe FASEB Journal, 2001
- Taurine transport at the blood-brain barrier: an in vivo brain perfusion studyBrain Research, 1995
- Effects of Taurine and Hypotaurine on Lipid PeroxidationBiochemical and Biophysical Research Communications, 1995
- Taurine‐Induced Regeneration of Goldfish Retina in Culture May Involve a Calcium‐Mediated MechanismJournal of Neurochemistry, 1993
- Potentiation of L‐Glutamate and L‐Aspartate Excitation of Cat Spinal Neurones by the Stereoisomers of threo‐3‐HydroxyaspartateJournal of Neurochemistry, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976